ASGR1 and metabolic dysfunction-associated steatohepatitis: Significantly greater ASGR1+/global EV expression was also observed for miR-128-3p between NASH and control subjects (p = 0.022) (Figure 4c), while a similar difference in miR-192 fell short of statistical significance (p = 0.067) (Figure 4b).